TBPH
Theravance Biopharma Inc
Price:  
16.56 
USD
Volume:  
1,140,481.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH Stock Forecast & Price Target

TBPH Stock Price Forecast

The average stock forecast for Theravance Biopharma Inc (TBPH) in the next 12 months is 17.75 USD. This price target corresponds to an upside of 7.17%. The range of stock forecasts for TBPH is 15.15 - 22.05 USD. Based on the ratings of 12 analysts, the consensus recommendation for TBPH is BUY.
Target Low Average Median High
Price (USD) 15.15 17.75 17.34 22.05
Upside -8.51% 7.17% 4.71% 33.15%

Recommendation Trends

The latest consensus rating for TBPH is "BUY". This is the average recommendation of 12 analysts: 0 strong sell, 0 sell, 4 hold, 5 buy, 3 strong buy. In the previous period, 12 analysts also majorly recommmended "BUY" for TBPH.

TBPH Financial Stock Forecast

Revenue This Year
105.51M
-1.82%
from 107.46M
Revenue Next Year
99.53M
-5.66%
from 105.51M
EPS This Year
1.83
-10.75%
from 2.05
EPS Next Year
0.33
-81.80%
from 1.83